Igor Cima

Title: Igor Cima: Pioneering Innovations in Cancer Diagnostics

Introduction

Igor Cima is an innovative inventor based in Singapore, renowned for his contributions to the field of cancer diagnostics. With a portfolio of 4 patents, his work focuses on advanced methodologies and devices that enhance the detection and management of specific cancer types.

Latest Patents

Among his most recent inventions is a groundbreaking column-based device for the retrieval of rare cells based on size. This device features an inner chamber with inlet and outlet openings, a perforated plug, a sleeve insert with a channel, and a filtering mechanism designed for the isolation of tumor-derived endothelial cell clusters (TECCs). These TECCs are characterized by multiple nuclei and specific markers significant in cancer diagnostics. The device also includes methods, reagents, and kits that aid in diagnosing and prognosing cancers by detecting TECCs from blood samples.

Additionally, Cima developed a multigene assay that offers an in vitro method for identifying the type of fibroepithelial tumor of the breast. This method involves profiling the differential activity of various genes to determine the nature of the tumor, providing essential insights for effective treatment management.

Career Highlights

Igor Cima has made significant strides in his career by working with esteemed organizations such as the Agency for Science, Technology and Research and Lucence Life Sciences Pte Ltd. His environment has allowed him to blend scientific research with practical applications, pushing the boundaries of cancer diagnostics.

Collaborations

Throughout his career, Igor has collaborated with notable professionals, including Min-Han Tan and Jackie Yi-Ru Ying. These partnerships have contributed to the development and refinement of his innovative technologies, facilitating knowledge exchange and fostering advancements in the medical field.

Conclusion

Igor Cima stands out as a prominent figure in the realm of cancer diagnostics, with a specialization in the retrieval of rare cells and multigene assays. His contributions not only underscore his inventiveness but also promise significant benefits for cancer diagnosis and treatment methodologies. Through his ongoing work, Cima continues to pave the way for future innovations that aim to improve patient outcomes in the field of oncology.